File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Limited argon laser peripheral iridoplasty as immediate treatment for an acute attack of primary angle closure glaucoma: A preliminary study

TitleLimited argon laser peripheral iridoplasty as immediate treatment for an acute attack of primary angle closure glaucoma: A preliminary study
Authors
Issue Date1999
PublisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/eye
Citation
Eye, 1999, v. 13 n. 1, p. 26-30 How to Cite?
AbstractPurpose. To study the efficacy and safety of limited (180°) argon laser peripheral iridoplasty (ALPI) as a first-line treatment for acute primary angle closure glaucoma (PACG) without the use of systemic anti-glaucomatous medications. Methods. Ten consecutive patients with PACG were recruited into the study. Each patient received topical pilocarpine (4%) and timolol (0.5%), and immediate limited ALPI as primary treatment. The intraocular pressures at 15, 30 and 60 min after ALPI were documented by Goldmann applanation tonometry. Results. The mean intraocular pressure (IOP) of this group of patients was reduced from 57.9 ± 10.6 mmHg to 39.0 ± 10.9 mmHg at 15 min, 28.3 ± 9.1 mmHg at 30 min and 20.4 ± 9.0 mmHg at 60 min after ALPI. No complications were encountered. In 8 of the 10 patients the corneal oedema cleared 1 h after ALPI. In the remaining 2 patients the corneal oedema cleared 2 h after ALPI. Conclusion. Immediate limited ALPI, without adjunctive systemic anti-glaucomatous medications, appeared to be effective and safe in controlling the IOP in treating acute PACG with a duration of attack ≤ 48 h. It may be as effective as 360°ALPI, and therefore has a role in those patients in whom 360°treatment is not possible.
Persistent Identifierhttp://hdl.handle.net/10722/176357
ISSN
2015 Impact Factor: 2.213
2015 SCImago Journal Rankings: 1.132
References

 

DC FieldValueLanguage
dc.contributor.authorLai, JSMen_US
dc.contributor.authorTham, CCYen_US
dc.contributor.authorLam, DSCen_US
dc.date.accessioned2012-11-26T09:10:47Z-
dc.date.available2012-11-26T09:10:47Z-
dc.date.issued1999en_US
dc.identifier.citationEye, 1999, v. 13 n. 1, p. 26-30en_US
dc.identifier.issn0950-222Xen_US
dc.identifier.urihttp://hdl.handle.net/10722/176357-
dc.description.abstractPurpose. To study the efficacy and safety of limited (180°) argon laser peripheral iridoplasty (ALPI) as a first-line treatment for acute primary angle closure glaucoma (PACG) without the use of systemic anti-glaucomatous medications. Methods. Ten consecutive patients with PACG were recruited into the study. Each patient received topical pilocarpine (4%) and timolol (0.5%), and immediate limited ALPI as primary treatment. The intraocular pressures at 15, 30 and 60 min after ALPI were documented by Goldmann applanation tonometry. Results. The mean intraocular pressure (IOP) of this group of patients was reduced from 57.9 ± 10.6 mmHg to 39.0 ± 10.9 mmHg at 15 min, 28.3 ± 9.1 mmHg at 30 min and 20.4 ± 9.0 mmHg at 60 min after ALPI. No complications were encountered. In 8 of the 10 patients the corneal oedema cleared 1 h after ALPI. In the remaining 2 patients the corneal oedema cleared 2 h after ALPI. Conclusion. Immediate limited ALPI, without adjunctive systemic anti-glaucomatous medications, appeared to be effective and safe in controlling the IOP in treating acute PACG with a duration of attack ≤ 48 h. It may be as effective as 360°ALPI, and therefore has a role in those patients in whom 360°treatment is not possible.en_US
dc.languageengen_US
dc.publisherNature Publishing Group. The Journal's web site is located at http://www.nature.com/eyeen_US
dc.relation.ispartofEyeen_US
dc.subject.meshAcute Diseaseen_US
dc.subject.meshAdrenergic Beta-Antagonists - Therapeutic Useen_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 And Overen_US
dc.subject.meshCombined Modality Therapyen_US
dc.subject.meshDrug Therapy, Combinationen_US
dc.subject.meshFemaleen_US
dc.subject.meshGlaucoma, Angle-Closure - Drug Therapy - Surgeryen_US
dc.subject.meshHumansen_US
dc.subject.meshIris - Surgeryen_US
dc.subject.meshLaser Therapy - Methodsen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshParasympathomimetics - Therapeutic Useen_US
dc.subject.meshPilocarpine - Therapeutic Useen_US
dc.subject.meshPreanesthetic Medicationen_US
dc.subject.meshTime Factorsen_US
dc.subject.meshTimolol - Therapeutic Useen_US
dc.titleLimited argon laser peripheral iridoplasty as immediate treatment for an acute attack of primary angle closure glaucoma: A preliminary studyen_US
dc.typeArticleen_US
dc.identifier.emailLai, JSM: laism@hku.hken_US
dc.identifier.authorityLai, JSM=rp00295en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1038/eye.1999.5-
dc.identifier.pmid10396379-
dc.identifier.scopuseid_2-s2.0-0033035479en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0033035479&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume13en_US
dc.identifier.issue1en_US
dc.identifier.spage26en_US
dc.identifier.epage30en_US
dc.publisher.placeUnited Kingdomen_US
dc.identifier.scopusauthoridLai, JSM=7401939748en_US
dc.identifier.scopusauthoridTham, CCY=7006081241en_US
dc.identifier.scopusauthoridLam, DSC=35500200200en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats